市場調査レポート

商品コード

1633601

心臓インプラントの市場規模、シェア、成長分析：デバイスタイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Cardiac Implants Market Size, Share, Growth Analysis, By Device Type (Pacemaker Devices, Cardiac Resynchronization Therapy Devices), By Application (Arrhythmias, Myocardial Ischemia), By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年01月14日
発行: SkyQuest
ページ情報: 英文 244 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 3,500 504,210円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 4,400 633,864円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 5,300 763,518円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

心臓インプラントの世界市場規模は2023年に161億米ドルとなり、予測期間（2025-2032年）のCAGRは6.3%で、2024年の171億1,000万米ドルから2032年には279億米ドルに成長する見通しです。

世界の心臓インプラント市場は、心血管疾患の有病率の上昇、技術革新、高齢化によって力強い成長を遂げています。座りがちなライフスタイルの増加、肥満や糖尿病などの健康問題が心臓インプラントの需要を高めており、患者のQOLを高める重要な治療オプションと考えられています。小型化やワイヤレス接続などの技術進歩により、ペースメーカーや除細動器などの機器の効率や使い勝手が向上しています。しかし、市場は、低所得地域での利用を制限する高額な費用、新製品の導入を遅らせる厳しい規制のハードル、長期的な性能や潜在的な合併症に関する懸念などの課題に直面しています。心臓インプラント分野でイノベーションを促進し、患者の安全を確保するためには、こうした課題に対処することが不可欠です。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Medtronic（USA）
Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Biotronik SE & Co. KG（Germany）
Lepu Medical Technology Co., Ltd.（China）
LivaNova PLC（UK）
Osypka AG（Germany）
Oscor Inc.（USA）
Pacetronix（India）
Medico S.p.A.（Italy）
MicroPort Scientific Corporation（China）
Shree Pacetronix Ltd.（India）
Biotricity Inc.（USA）
Cardiac Science Corporation（USA）
EBR Systems, Inc.（USA）
Jarvik Heart, Inc.（USA）
Berlin Heart GmbH（Germany）
ReliantHeart Inc.（USA）
SynCardia Systems, LLC（USA）
BiVacor（USA）

結論と推奨事項

Product Code: SQMIG35A2355

Global Cardiac Implants Market size was valued at USD 16.1 billion in 2023 and is poised to grow from USD 17.11 billion in 2024 to USD 27.9 billion by 2032, growing at a CAGR of 6.3% during the forecast period (2025-2032).

The global cardiac implants market is experiencing robust growth, propelled by the rising prevalence of cardiovascular diseases, technological innovations, and an aging demographic. Increasing sedentary lifestyles and health issues, such as obesity and diabetes, are heightening the demand for cardiac implants, which are viewed as vital treatment options to enhance patient quality of life. Technological advancements, including miniaturization and wireless connectivity, are improving the efficiency and user-friendliness of devices like pacemakers and defibrillators. However, the market faces challenges, including high costs that limit accessibility in low-income areas, stringent regulatory hurdles that can delay new product introduction, and concerns regarding long-term performance and potential complications. Addressing these challenges is essential for fostering innovation and ensuring patient safety in the cardiac implants sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Implants Market Segmental Analysis

Global Cardiac Implants Market is segmented by Device Type, Application, End User and region. Based on Device Type, the market is segmented into Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve and Others. Based on Application, the market is segmented into Arrhythmias, Myocardial Ischemia, Acute Myocardial Infraction, Congestive Heart Failure and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Implants Market

One of the key factors propelling the global cardiac implants market is the escalating incidence of cardiovascular diseases, encompassing conditions such as heart failure, arrhythmias, and coronary artery disease. This rise can be attributed to various contributors, including increasingly sedentary lifestyles, poor dietary choices, and a rapidly aging population. As these factors lead to a greater prevalence of cardiovascular issues, the demand for cardiac implants intensifies, thereby driving market growth. The urgent need for effective treatment options to manage these conditions highlights the significance of the cardiac implants sector in addressing the healthcare challenges posed by cardiovascular diseases.

Restraints in the Global Cardiac Implants Market

One of the significant challenges facing the global cardiac implants market is the rigorous regulatory approval processes that manufacturers must navigate. Compliance with the stringent standards set by regulatory authorities, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), can often be a lengthy and expensive undertaking. This extensive vetting process can result in delays for the launch of new technologies and products, hindering innovation and stifling the overall growth of the market. As a result, these regulatory hurdles create a restrictive environment for the advancement of cardiac implant solutions.

Market Trends of the Global Cardiac Implants Market

The Global Cardiac Implants market is experiencing a notable shift towards the integration of remote monitoring and digital health solutions, reflecting a burgeoning trend in patient care. This innovation facilitates continuous oversight of patients' cardiac health and device functionality, empowering healthcare providers to deliver prompt interventions and tailored treatment plans. By leveraging these technologies, the market is not only enhancing patient management but also significantly reducing hospital readmissions, thereby improving overall healthcare efficiency. As patient-centered care gains prominence, the adoption of remote monitoring solutions is poised to reshape the cardiac implants landscape, driving growth and innovation within the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Cardiac Implants Market Size by Device Type & CAGR (2025-2032)

Market Overview
Pacemaker Devices
Cardiac Resynchronization Therapy Devices
Implantable Hemodynamic Monitoring Devices
Implanted Heart Rhythm Monitors
Coronary Stents
Implantable Cardioverter Defibrillator
Heart Valve
Others

Global Cardiac Implants Market Size by Application & CAGR (2025-2032)

Market Overview
Arrhythmias
Myocardial Ischemia
Acute Myocardial Infraction
Congestive Heart Failure
Others

Global Cardiac Implants Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Others

Global Cardiac Implants Market Size & CAGR (2025-2032)

North America (Device Type, Application, End User)
- US
- Canada
Europe (Device Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Device Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Device Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Device Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oscor Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacetronix (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medico S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shree Pacetronix Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotricity Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardiac Science Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EBR Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jarvik Heart, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berlin Heart GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ReliantHeart Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SynCardia Systems, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BiVacor (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

心臓インプラントの市場規模、シェア、成長分析：デバイスタイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Cardiac Implants Market Size, Share, Growth Analysis, By Device Type (Pacemaker Devices, Cardiac Resynchronization Therapy Devices), By Application (Arrhythmias, Myocardial Ischemia), By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

心臓インプラント市場規模：デバイスタイプ別& CAGR（2025-2032）

心臓インプラント市場規模：用途別& CAGR（2025-2032）

心臓インプラント市場規模：エンドユーザー別& CAGR（2025-2032）

心臓インプラント市場規模：地域別& CAGR（2025-2032）